Penicillin and Gliclazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Penicillin (penicillin g potassium) and Gliclazide (gliclazide). Common drug interactions include gastric disorder among females and ascites among males.

The phase IV clinical study analyzes what interactions people have when they take Penicillin and Gliclazide. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Penicillin?

Penicillin has active ingredients of penicillin g potassium. It is often used in strep throat. eHealthMe is studying from 8,567 Penicillin users. Check the latest studies of Penicillin.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.



On Jul, 20, 2026

58 people who take Penicillin and Gliclazide together, and have interactions are studied.

Penicillin and Gliclazide drug interactions.

What are the common drug interactions of Penicillin and Gliclazide, by gender? *:

female:

  1. Gastric disorder (disease of stomach)
  2. Drug intolerance (drug sensitivity)
  3. Abdominal discomfort
  4. Abdominal pain upper
  5. Dyspnoea (difficult or laboured respiration)
  6. Rash
  7. Drug ineffective
  8. Drug hypersensitivity
  9. Hypertension (high blood pressure)
  10. Arthralgia (joint pain)

male:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Cardiac failure congestive
  3. Lower respiratory tract infection
  4. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Multimorbidity (co-occurrence of two or more chronic medical conditions in one person)
  7. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  8. Oesophageal carcinoma (cancer tumour of oesophagus)
  9. Oesophageal perforation (hole in oesophagus)
  10. Pleural effusion (water on the lungs)

What are the common drug interactions of Penicillin and Gliclazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hospitalisation
  2. Hypersensitivity
  3. Pain
  4. Gastric disorder (disease of stomach)
  5. Abdominal discomfort
  6. Abdominal pain upper
  7. Arthralgia (joint pain)
  8. Cardiac failure congestive
  9. Cough
  10. Diarrhoea

50-59:

  1. Abdominal discomfort
  2. Abdominal pain upper
  3. Arthralgia (joint pain)
  4. Cardiac failure
  5. Cardiac failure congestive
  6. Cough
  7. Diarrhoea
  8. Drug hypersensitivity
  9. Drug ineffective
  10. Drug intolerance (drug sensitivity)

60+:

  1. Rash
  2. Dyspnoea (difficult or laboured respiration)
  3. Immunosuppressant drug level increased
  4. Inflammatory marker increased
  5. Lower respiratory tract infection
  6. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Multimorbidity (co-occurrence of two or more chronic medical conditions in one person)
  9. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  10. Oesophageal carcinoma (cancer tumour of oesophagus)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 36 people, 62.07%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 24 people, 41.38%
  3. Abdominal Discomfort: 22 people, 37.93%
  4. Adenocarcinoma Pancreas (cancer of pancreas): 7 people, 12.07%
  5. Pain: 6 people, 10.34%
  6. Type 2 Diabetes: 5 people, 8.62%
  7. Pneumonia: 5 people, 8.62%
  8. Lower Respiratory Tract Infection: 5 people, 8.62%
  9. Diarrhea: 5 people, 8.62%
  10. Adenomatous Polyposis Coli ((fap) is an inherited condition in which numerous polyps form mainly in the epithelium of the large intestine): 4 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Penicillin and Gliclazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Penicillin and Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Penicillin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Penicillin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gliclazide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on penicillin g potassium and gliclazide (the active ingredients of Penicillin and Gliclazide, respectively), and Penicillin and Gliclazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: